Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.53%16.612.0%$163.34m
PRGOPerrigo Co. Plc
-1.50%44.526.8%$125.64m
SAGESAGE Therapeutics, Inc.
2.77%135.609.5%$118.42m
JAZZJazz Pharmaceuticals Plc
0.13%128.172.2%$94.28m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.05%128.616.3%$74.28m
PTLAPortola Pharmaceuticals, Inc.
2.37%25.537.7%$61.81m
ICPTIntercept Pharmaceuticals, Inc.
-1.13%110.8018.6%$54.35m
MNKMallinckrodt Plc
0.30%20.0121.1%$45.03m
CTLTCatalent Inc
1.67%34.642.4%$41.21m
AXSMAxsome Therapeutics, Inc.
1.51%8.062.7%$40.50m
UTHRUnited Therapeutics Corporation
-1.16%113.6214.4%$39.59m
ICLRICON Plc
-1.85%133.804.1%$39.58m
ENDPEndo International Plc
0.31%9.668.9%$36.88m
HZNPHorizon Pharma plc
-1.04%21.927.4%$30.81m
MDCOMedicines Company
-0.20%19.8021.8%$29.37m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.